Arcus Biosciences Inc (RCUS)
Healthcare
Biotechnology
27.60 $
-2.0%
vs. previous close
Closing price · As of: 3. Aug 2026
Arcus Biosciences Inc (RCUS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -138 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -57 | -63 | -88 | -2.0 | -94 | 26 | -100 | -132 | -133 | -97 | -120 | -138 | -488 | |
| 2.0 | 1.0 | 5.0 | 3.0 | 2.0 | 2.0 | 3.0 | 3.0 | 2.0 | 2.0 | 3.0 | 2.0 | 9.0 | |
| 18 | 18 | 18 | 20 | 20 | 19 | 17 | 16 | 15 | 14 | 15 | 19 | 63 | |
| 18 | 16 | – | – | – | – | – | – | – | – | – | – | – | |
| 13 | -9.0 | -24 | -37 | -19 | 101 | -23 | -37 | -148 | 21 | -30 | -31 | -188 | |
| 5.0 | 10 | 6.0 | 4.0 | 0.0 | 1.0 | 1.0 | 1.0 | 0.0 | 0.0 | 1.0 | 0.0 | 1.0 | |
| 26 | 11 | 28 | -169 | 63 | -29 | 51 | 32 | 137 | 79 | -182 | 114 | 148 | |
| 23 | – | – | – | -1.0 | 1.0 | – | – | – | – | – | – | – | |
| – | – | – | – | – | 47 | 0.0 | – | – | 0.0 | 0.0 | – | – | |
| 23 | 6.0 | 3.0 | 229 | 2.0 | 48 | -2.0 | 142 | 52 | 8.0 | 286 | 3.0 | 349 | |
| -8.0 | -46 | -57 | 58 | -29 | 45 | -51 | 42 | 56 | -10 | -16 | -21 | 9.0 | |
| -62 | -73 | -94 | -6.0 | -94 | 25 | -101 | -133 | -133 | -97 | -121 | -138 | -489 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.